{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:18:33Z","timestamp":1791962313581,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1-CA237660"],"award-info":[{"award-number":["RO1-CA237660"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006377","name":"Purdue University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2022\/007389"],"award-info":[{"award-number":["CRG\/2022\/007389"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bmc.2023.117459","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T12:05:21Z","timestamp":1692878721000},"page":"117459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis and anticancer activity of N-aryl indolylsulfoximines: Identification of potent and selective anticancer agents"],"prefix":"10.1016","volume":"93","author":[{"given":"Monika","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey","family":"Lotana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-1305","authenticated-orcid":false,"given":"Kavita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-2040","authenticated-orcid":false,"given":"Dalip","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117459_b0005","doi-asserted-by":"crossref","first-page":"14243","DOI":"10.1021\/acs.jmedchem.0c00960","article-title":"Sulfoximines as rising stars in modern drug discovery? Current status and perspective on an emerging functional group in medicinal chemistry","volume":"63","author":"M\u00e4der","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.drudis.2011.10.024","article-title":"Classification of scaffold-hopping approaches","volume":"17","author":"Sun","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117459_b0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","article-title":"Clinical implications of the p53 tumor-suppressor gene","volume":"329","author":"Harris","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2023.117459_b0020","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s00018-005-5330-x","article-title":"Understanding microtubule dynamics for improved cancer therapy","volume":"62","author":"Honore","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmc.2023.117459_b0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1081\/CNV-200055970","article-title":"Tubulin function, action of antitubulin drugs, and new drug development","volume":"23","author":"Pellegrini","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bmc.2023.117459_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2023.117459_b0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/biom13020249","article-title":"Identification of inhibitors of tubulin polymerization using a CRISPR-edited cell line with endogenous fluorescent tagging of \u03b2-tubulin and histone H1","volume":"13","author":"Khachatryan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2023.117459_b0040","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1021\/jm100884b","article-title":"Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents","volume":"53","author":"Chen","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0045","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1016\/j.bmc.2011.06.084","article-title":"Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization","volume":"19","author":"Chen","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0050","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1021\/jm300564b","article-title":"Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents","volume":"55","author":"Chen","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0055","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2017.04.078","article-title":"Design and synthesis of bis (indolyl) ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors","volume":"136","author":"Tantak","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceb.2009.11.008","article-title":"From signaling pathways to microtubule dynamics: the key players","volume":"22","author":"Etienne-Manneville","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bmc.2023.117459_b0065","first-page":"214","article-title":"Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity. Involvement of ROS and GADD153 upsteam of mitochondria-dependent apoptosis in HCT116 cells","volume":"2","author":"k. Yu-Feng, Y. Z. Su, Y. H. Tseng, S. Y. Wang, H. M. Wang and P. J. Chueh.","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bmc.2023.117459_b0070","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1021\/jm4016284","article-title":"Design, synthesis, and structure\u2013activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility","volume":"57","author":"Cao","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0075","doi-asserted-by":"crossref","unstructured":"Feng Z, Lu X, Gan L, Zhang Q, Lin L. Xanthones, a promising anti-inflammatory scaffold: structure, activity, and drug likeness analysis. Molecules. 200;25: 598.","DOI":"10.3390\/molecules25030598"},{"key":"10.1016\/j.bmc.2023.117459_b0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2019.04.043","article-title":"Antibacterial activity study of 1, 2, 4-triazole derivatives","volume":"173","author":"Gao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112714","article-title":"Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies","volume":"206","author":"Ren","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.05.025","article-title":"Indoles\u2014A promising scaffold for drug development","volume":"91","author":"Sravanthi","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmc.2023.117459_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anti-cancer activities: An overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0100","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/jm900016t","article-title":"New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies","volume":"52","author":"La Regina","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0105","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1158\/1078-0432.CCR-08-0550","article-title":"N-(2, 6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer","volume":"14","author":"Wang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117459_b0110","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1021\/jm049360d","article-title":"Arylthioindoles, potent inhibitors of tubulin polymerization","volume":"47","author":"De Martino","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejmech.2018.11.038","article-title":"Synthesis, biological evaluation, and molecular docking investigation of 3-amidoindoles as potent tubulin polymerization inhibitors","volume":"162","author":"Chen","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0120","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/cmdc.201000228","article-title":"Synthesis of anti-microtubule N-(2-Arylindol-7-yl) benzenesulfonamide derivatives and their antitumor mechanisms","volume":"5","author":"Chiou","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117459_b0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejmech.2016.09.091","article-title":"Sulfoximines from a medicinal chemist's perspective: physicochemical and in vitro parameters relevant for drug discovery","volume":"126","author":"Frings","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0130","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1055\/s-0036-1590874","article-title":"Straightforward strategies for the preparation of NH-sulfoximines: a serendipitous story","volume":"28","author":"Bull","year":"2017","journal-title":"Synlett"},{"key":"10.1016\/j.bmc.2023.117459_b0135","doi-asserted-by":"crossref","unstructured":"L\u00fccking U. Sulfoximines: a neglected opportunity in medicinal chemistry. Angew Chem, In Ed 2019;52: 9399-9408.","DOI":"10.1002\/anie.201302209"},{"key":"10.1016\/j.bmc.2023.117459_b0140","doi-asserted-by":"crossref","unstructured":"Chinthakindi PK, Naicker T, Thota N, Govender T, Kruger HG, Arvidsson PI. Sulfonimidamides in medicinal and agricultural chemistry. Angew. Chem., In. Ed. 56 (2017) 4100-4109.","DOI":"10.1002\/anie.201610456"},{"key":"10.1016\/j.bmc.2023.117459_b0145","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cmdc.201700447","article-title":"Identification of atuveciclib (BAY 1143572), the first highly selective, clinical PTEFb\/CDK9 inhibitor for the treatment of cancer","volume":"12","author":"L\u00fccking","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117459_b0150","series-title":"Discovery and characterization of AZD6738, a potent inhibitor of ataxia telangiectasia mutated and Rad3 related (ATR) kinase with application as an anticancer agent","author":"Foote","year":"2018"},{"key":"10.1016\/j.bmc.2023.117459_b0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cmdc.201700044","article-title":"Novel pieces for the emerging picture of sulfoximines in drug discovery: synthesis and evaluation of sulfoximine analogues of marketed drugs and advanced clinical candidates","volume":"12","author":"Sirvent","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117459_b0160","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1039\/C8QO01233D","article-title":"Neglected sulfur (VI) pharmacophores in drug discovery: exploration of novel chemical space by the interplay of drug design and method development","volume":"6","author":"L\u00fccking","year":"2019","journal-title":"Org Chem Front"},{"key":"10.1016\/j.bmc.2023.117459_b0165","doi-asserted-by":"crossref","unstructured":"Zenzola M, Doran R, Degennaro L, Luisi R, Bull JA. Transfer of electrophilic NH using convenient sources of ammonia: direct synthesis of NH sulfoximines from sulfoxides. Angew Chem, In Ed 2016;128: 7319-7323.","DOI":"10.1002\/ange.201602320"},{"key":"10.1016\/j.bmc.2023.117459_b0170","first-page":"348","article-title":"Synthesis of NH-sulfoximines from sulfides by chemoselective one-pot N-and O-transfers","volume":"53","author":"Tota","year":"2017","journal-title":"ChemComm."},{"key":"10.1016\/j.bmc.2023.117459_b0175","first-page":"2064","article-title":"Mechanistic investigation of the NH-sulfoximination of sulfide. Evidence for \u03bb 6-sulfanenitrile intermediates","volume":"53","author":"Lohier","year":"2017","journal-title":"ChemComm."},{"key":"10.1016\/j.bmc.2023.117459_b0180","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/s-0037-1610316","article-title":"Late-stage sulfoximination: improved synthesis of the anticancer drug candidate atuveciclib","volume":"51","author":"Glachet","year":"2019","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2023.117459_b0185","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.add1383","article-title":"Late-stage diversification of indole skeletons through nitrogen atom insertion","volume":"377","author":"Reisenbauer","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117459_b0190","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/slct.201700132","article-title":"Sulfimine-promoted fast o transfer: one\u2013step synthesis of sulfoximine from sulfide","volume":"2","author":"Xie","year":"2017","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2023.117459_b0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/jhet.5570300306","article-title":"The reaction of pyrroles with trimethylhalosilanes-dialkyl sulfoxides","volume":"30","author":"Bellesia","year":"1993","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113590","article-title":"A comprehensive assessment of a new series of 5\u2032, 6\u2032-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs)","volume":"222","author":"Riu","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117459_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117459_b0210","first-page":"3791","article-title":"Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole","volume":"29","author":"Chu","year":"2009","journal-title":"Anticancer Res"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:23:48Z","timestamp":1760837028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":42,"alternative-id":["S0968089623003073"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117459","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anticancer activity of N-aryl indolylsulfoximines: Identification of potent and selective anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117459"}}